H. J. Rupprecht - Concepedia

Concepedia

Author

H. J. Rupprecht

Johannes Gutenberg University Mainz

Also Known As

H J Rupprecht, H Rupprecht, H. -J. Rupprecht, H. J. RUPPRECHT, H. J. Rupprecht, H. Rupprecht, H.-J. Rupprecht, H.J Rupprecht, H.J. Rupprecht, Hans-Jurgen Rupprecht

57

Publications

2.4K

Citations

15

H-Index

44

Concepts

All Affiliations

Johannes Gutenberg University Mainz University Medical Center of the Johannes Gutenberg University Mainz Bundeswehrzentralkrankenhaus Koblenz Inserm Sorbonne Université

HJ

About

H. J. Rupprecht is an author at Johannes Gutenberg University Mainz specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	257
2	Public Health	6	6	148
3	Emergency Medicine	4	4	92
4	Epidemiology	3	3	99
5	Biochemistry	1	1	25

H. J. Rupprecht

×

18

Publications

2.4K

Citations

15

H-Index

	Year	Citations
Bivalirudin for Patients with Acute Coronary Syndromes Gregg W. Stone, Brent McLaurin, David A. Cox, New England Journal of Medicine	2006	1.4K
Genetic Analysis of the Interleukin-18 System Highlights the Role of the Interleukin-18 Gene in Cardiovascular Disease Laurence Tiret, Tiphaine Godefroy, Edith Lubos, Circulation	2005	230
Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study Sanjit S. Jolly, Janice Pogue, K. Haladyn, European Heart Journal	2008	133
Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study Renate B. Schnabel, Claudia‐Martina Messow, Edith Lubos, European Heart Journal	2008	129
Haemostatic Factors and the Risk of Cardiovascular Death in Patients With Coronary Artery Disease Pierre‐Emmanuel Morange, Christoph Bickel, Viviane Nicaud, Arteriosclerosis Thrombosis and Vascular Biology	2006	101
Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study Pierre‐Emmanuel Morange, David‐Alexandre Trégouët, Tiphaine Godefroy, Journal of Molecular Medicine InflammationVascular DiseaseCardiovascular EpidemiologyCardiovascular DiseaseAtherogene Study	2008	51
Short-and long-term outcome after PTCA in patients with stable and unstable angina H. J. Rupprecht, R. Brennecke, M. Kottmeyer, European Heart Journal Percutaneous Coronary InterventionThrombosisCoronary Heart DiseaseCardiovascular DiseaseAtherosclerosis	1990	47
SELPLG Gene Polymorphisms in Relation to Plasma SELPLG Levels and Coronary Artery Disease David‐Alexandre Trégouët, Sandrine Barbaux, Odette Poirier, Annals of Human Genetics	2003	45
Cost of atherothrombotic diseases—myocardial infarction, ischaemic stroke and peripheral arterial occlusive disease—in Germany Bernd Brüggenjürgen, H. J. Rupprecht, Stefan N. Willich, Journal of Public Health ThrombosisCardiovascular DiseaseHealth EconomicsIschemic StrokeAtherothrombotic Diseases—myocardial Infarction	2005	32
Evaluation of an automated chromogenic substrate assay for the rapid determination of hirudin in plasma Gerd Häfner, Karl Fickenscher, Heinz-Jürgen Friesen, Thrombosis Research Rapid DeterminationBiochemistryMedicineBioanalysisHematology	1995	25

Page 1